Dr. Neelesh Sharma is graduated in Veterinary Science in 2001 and post-graduated in Veterinary Medicine in 2003. Dr Sharma focused on Stem cell based research in livestock during Ph.D. from Jeju National University, South Korea; and presently working as Senior Assistant Professor in the Division of Veterinary Medicine, Faculty of Veterinary Science & Animal Husbandry, Sher-e-Kashmir University of Agricultural Sciences & Technology of Jammu (SKUAST-J), India. He has more than 13 years experience in teaching, research and extension. Since more than 12 years he working on mastitis in dairy animals and authored a book on “Bovine Mastitis”. He has successfully isolated, characterized and established Korean Holstein cow mammary epithelial/stem cell lines.
Dr. Neelesh Sharma is a “ICAR-International Fellow”. He has bestowed with numerous National and International awards such as The Bronze Standard International Award by HRH The Duke of Edinburgh, UK; NAAS Associateship, Graduate student award, Beijing China; Outstanding Presentation Award, South Korea; Outstanding Research Scholarship award, Thailand; Dr. D.C. Blood Gold Medal Award, IAAVR Merit Award etc. and recipient of various best poster/presentation awards at national and international level. He has authored/edited 10 books/compendiums and >140 papers in journals of repute. Dr. Neelesh Sharma is founder Editor-In-Chief, Journal of Animal Research having NAAS and technical editor/regional editor/editorial board member of about 20 scientific journals. He is member of various scientific societies and has attended many conferences at National and International level.
The present focus of Dr. Neelesh Sharma’s research is to find our most suitable potent therapeutic option for the management of mastitis in dairy animals using different aspects such stem cell based and nano-particles based approach. He has used various antibacterial proteins and their genes transfected into cow mammary stem cells. Transfected antibacterial proteins secreted by stem cells and showed strong anti-bacterial activity against mastitis isolates. Nano-particles based approach can surmount the issue of improper contact of microorganisms and drugs due to intracellular property of few organisms. He assumes that nano-particles based approach can also improve the targeted drug delivery system and reduce the dose of drug, which directly affect the treatment cost.
